SKYRIZI 150 MG/ML SOL INJ CARP PLAS TRANS X 2,4 ML + DISP AUTOINJ
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1986000160032 -
GGREM
543724110005507 -
Código de barras
8054083023397
O que a fonte publica
- Detentor do registro
- ABBVIE FARMACÊUTICA LTDA.
- Princípios ativos
- RISANQUIZUMABE
- Embalagem
- 150 MG/ML SOL INJ CARP PLAS TRANS X 2,4 ML + DISP AUTOINJ
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Biológico
- Classe terapêutica
- L4C - INIBIDORES DA INTERLEUCINA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "SKYRIZI 150 MG/ML SOL INJ CARP PLAS TRANS X 2,4 ML + DISP AUTOINJ",
"holder": "ABBVIE FARMACÊUTICA LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"8054083023397"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "543724110005507",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "15.800.545/0001-50",
"priceRegime": "Regulado",
"productName": "SKYRIZI",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "150 MG/ML SOL INJ CARP PLAS TRANS X 2,4 ML + DISP AUTOINJ",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "45102.59",
"icms-12": "51252.96",
"icms-17": "54340.46",
"icms-18": "55003.15",
"icms-19": "55682.21",
"icms-20": "56378.24",
"icms-21": "57091.90",
"icms-22": "57823.82",
"icms-23": "58574.78",
"icms-17.5": "54669.80",
"icms-19.5": "56028.06",
"icms-20.5": "56732.83",
"icms-22.5": "58196.91",
"icms-12-alc": "45761.58",
"icms-17-alc": "48518.25",
"icms-18-alc": "49109.96",
"icms-19-alc": "49716.22",
"icms-20-alc": "50337.69",
"icms-21-alc": "50974.90",
"icms-22-alc": "51628.39",
"icms-23-alc": "52298.89",
"withoutTaxes": "40270.16",
"icms-17.5-alc": "48812.32",
"icms-19.5-alc": "50025.04",
"icms-20.5-alc": "50654.27",
"icms-22.5-alc": "51961.48"
},
"pisCofinsList": "Negativa",
"substanceText": "RISANQUIZUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "60503.52",
"icms-12": "68754.02",
"icms-17": "72895.79",
"icms-18": "73784.77",
"icms-19": "74695.70",
"icms-20": "75629.40",
"icms-21": "76586.75",
"icms-22": "77568.60",
"icms-23": "78575.98",
"icms-17.5": "73337.59",
"icms-19.5": "75159.65",
"icms-20.5": "76105.07",
"icms-22.5": "78069.08",
"icms-12-alc": "63262.70",
"icms-17-alc": "67073.63",
"icms-18-alc": "67891.64",
"icms-19-alc": "68729.76",
"icms-20-alc": "69588.90",
"icms-21-alc": "70469.81",
"icms-22-alc": "71373.22",
"icms-23-alc": "72300.15",
"withoutTaxes": "55671.14",
"icms-17.5-alc": "67480.17",
"icms-19.5-alc": "69156.68",
"icms-20.5-alc": "70026.56",
"icms-22.5-alc": "71833.70"
},
"invalidBarcodes": [],
"activeSubstances": [
"RISANQUIZUMABE"
],
"therapeuticClass": "L4C - INIBIDORES DA INTERLEUCINA",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1986000160032",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L4C",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:543724110005507"